AU2011317627B2 - Cysteine and food intake - Google Patents

Cysteine and food intake Download PDF

Info

Publication number
AU2011317627B2
AU2011317627B2 AU2011317627A AU2011317627A AU2011317627B2 AU 2011317627 B2 AU2011317627 B2 AU 2011317627B2 AU 2011317627 A AU2011317627 A AU 2011317627A AU 2011317627 A AU2011317627 A AU 2011317627A AU 2011317627 B2 AU2011317627 B2 AU 2011317627B2
Authority
AU
Australia
Prior art keywords
cysteine
nutritional composition
used according
composition
food intake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011317627A
Other languages
English (en)
Other versions
AU2011317627A1 (en
Inventor
Denis Breuille
Isabelle Papet
Karine Vidal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43304791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2011317627(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2011317627A1 publication Critical patent/AU2011317627A1/en
Assigned to NESTEC S.A. reassignment NESTEC S.A. Request for Assignment Assignors: INRA, NESTEC S.A.
Application granted granted Critical
Publication of AU2011317627B2 publication Critical patent/AU2011317627B2/en
Assigned to Société des Produits Nestlé S.A. reassignment Société des Produits Nestlé S.A. Request for Assignment Assignors: NESTEC S.A.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2011317627A 2010-10-21 2011-10-19 Cysteine and food intake Active AU2011317627B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10188399A EP2444083A1 (en) 2010-10-21 2010-10-21 Cysteine and food intake
EP10188399.9 2010-10-21
PCT/EP2011/068231 WO2012052463A1 (en) 2010-10-21 2011-10-19 Cysteine and food intake

Publications (2)

Publication Number Publication Date
AU2011317627A1 AU2011317627A1 (en) 2013-05-23
AU2011317627B2 true AU2011317627B2 (en) 2016-06-02

Family

ID=43304791

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011317627A Active AU2011317627B2 (en) 2010-10-21 2011-10-19 Cysteine and food intake

Country Status (15)

Country Link
US (1) US9233090B2 (enExample)
EP (2) EP2444083A1 (enExample)
JP (1) JP6160832B2 (enExample)
CN (1) CN103269697A (enExample)
AU (1) AU2011317627B2 (enExample)
BR (1) BR112013009709A2 (enExample)
CA (1) CA2815109C (enExample)
DK (1) DK2629769T3 (enExample)
ES (1) ES2654344T3 (enExample)
MX (1) MX2013004371A (enExample)
PH (1) PH12013500761A1 (enExample)
RU (1) RU2013123062A (enExample)
SG (1) SG189935A1 (enExample)
WO (1) WO2012052463A1 (enExample)
ZA (1) ZA201303656B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
AU2018373653B2 (en) * 2017-11-21 2024-09-12 Societe Des Produits Nestle S.A. Compositions and methods using oleuropein or curcumin for muscle quality and/or muscle mass
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
WO2020163188A1 (en) * 2019-02-08 2020-08-13 Imbria Pharmaceuticals, Inc. Compositions containing n-acetylcysteine conjugated to a tca cycle intermediate
JP7655224B2 (ja) * 2019-10-25 2025-04-02 味の素株式会社 筋質向上剤
AU2023349972A1 (en) 2022-09-30 2025-05-08 Evonik Operations Gmbh Probiotic composition for the treatment of malnutrition

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
JPS62286923A (ja) * 1986-06-04 1987-12-12 Takao Shinoda 貧食作用増強剤
JPH05294833A (ja) * 1991-04-15 1993-11-09 Takeda Chem Ind Ltd ビタミン含有保健剤
US5627152A (en) * 1995-01-18 1997-05-06 Telluride Pharmaceutical Corporation Method for increasing bodyweight
WO2002015720A2 (en) * 2000-08-22 2002-02-28 Société des Produits Nestlé S. A. Nutritional composition an method for improving protein deposition
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US20090324518A1 (en) * 2005-12-27 2009-12-31 Consigllo Nazionale Delle Ricerche Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
DE4229166A1 (de) * 1992-09-01 1994-03-03 Deutsches Krebsforsch Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
RO119122B1 (ro) * 1998-02-02 2004-04-30 Dumitru Dobrescu Medicament geriatric
JP2004519241A (ja) * 2001-03-09 2004-07-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 高齢化に伴う生理的障害を改善し寿命を延ばす組成物
WO2006134135A2 (en) 2005-06-14 2006-12-21 Nestec S.A. Nutritional method for elderly people
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
JP2009001507A (ja) * 2007-06-19 2009-01-08 Ss Pharmaceut Co Ltd 体脂肪減少剤およびその利用
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
TWI515005B (zh) 2008-09-12 2016-01-01 ２４５８７８１加拿大公司 在接受化療或放療的患者中應用富含半胱胺酸之乳清衍生蛋白以增進患者存活時間
ES2621936T3 (es) 2008-10-17 2017-07-05 Nestec S.A. Método para preparar composiciones de proteína de suero de leche

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
JPS62286923A (ja) * 1986-06-04 1987-12-12 Takao Shinoda 貧食作用増強剤
JPH05294833A (ja) * 1991-04-15 1993-11-09 Takeda Chem Ind Ltd ビタミン含有保健剤
US5627152A (en) * 1995-01-18 1997-05-06 Telluride Pharmaceutical Corporation Method for increasing bodyweight
WO2002015720A2 (en) * 2000-08-22 2002-02-28 Société des Produits Nestlé S. A. Nutritional composition an method for improving protein deposition
US20050153019A1 (en) * 2000-08-22 2005-07-14 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20090324518A1 (en) * 2005-12-27 2009-12-31 Consigllo Nazionale Delle Ricerche Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MBODJI K et al, EFFECT OF A NEW ORAL SUPPLEMENT ENRICHED IN CYSTEINE ON NUTRITIONAL STATUS OF STRESSED RATS, CLINICAL NUTRITION SUPPLEMENTS, 2009, vol. 4, no. 2, page 123 *

Also Published As

Publication number Publication date
JP2014504261A (ja) 2014-02-20
PH12013500761A1 (en) 2017-08-23
WO2012052463A1 (en) 2012-04-26
ES2654344T3 (es) 2018-02-13
US20130225486A1 (en) 2013-08-29
CA2815109C (en) 2020-03-24
DK2629769T3 (en) 2018-01-02
ZA201303656B (en) 2014-11-26
EP2629769B1 (en) 2017-10-04
US9233090B2 (en) 2016-01-12
EP2444083A1 (en) 2012-04-25
JP6160832B2 (ja) 2017-07-12
RU2013123062A (ru) 2014-11-27
MX2013004371A (es) 2013-08-27
SG189935A1 (en) 2013-06-28
CN103269697A (zh) 2013-08-28
AU2011317627A1 (en) 2013-05-23
BR112013009709A2 (pt) 2016-07-19
CA2815109A1 (en) 2012-04-26
EP2629769A1 (en) 2013-08-28

Similar Documents

Publication Publication Date Title
AU2011317627B2 (en) Cysteine and food intake
AU2004222633B2 (en) Compositions comprising fatty acids and amino acids
US20210275582A1 (en) Composition of nutrition supplementation for nutritional deficiencies and method of use therefore
WO2012141316A1 (ja) 栄養組成物
JP2007519678A (ja) 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
JP2010506882A (ja) 維持のための長期経腸栄養供給
JP2024122087A (ja) 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法
WO2020009111A1 (ja) 脂肪蓄積抑制用組成物
JP2014504261A5 (enExample)
JP2019108364A (ja) 栄養組成物
CN116546981A (zh) 使用至少一种甘氨酸或其衍生物和/或至少一种n-乙酰半胱氨酸或其衍生物以及至少一种百里酚和/或香芹酚的组合物和方法
CN104619198A (zh) 含有β-羟基-β-甲基丁酸的组合物及其用途
WO2022255284A1 (ja) 妊婦用経口投与剤
JP2011046647A (ja) ポリ−γ−グルタミン酸を含有するコレステロール抑制剤
JP2019024389A (ja) 筋力向上用アミノ酸組成物
JP2011037715A (ja) 体重変動抑制剤
WO2013018706A1 (ja) Ｕｒａｔ１活性を調節するための組成物

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NESTEC S.A.

Free format text: FORMER APPLICANT(S): NESTEC S.A.; INRA

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SOCIETE DES PRODUITS NESTLE S.A.

Free format text: FORMER OWNER(S): NESTEC S.A.